Telehealth consultations successfully removed racial, age, and geographic barriers to autologous stem cell transplant access in a study of nearly 2,000 myeloma patients published in the journal Cancers. Researchers found that virtual visits leveled the playing field for older, Black, and rural patients who historically faced lower transplant rates.
Disparities in Traditional Stem Cell Transplant Access
For the first part of the study examining autologous stem cell transplant recipients, investigators identified significant demographic disparities. Patients who were older, identified as Black or African American, or lived in lower socioeconomic and rural environments—particularly Appalachian regions in Ohio—were the least likely to receive a stem cell transplant within a patient population of nearly 2,000 individuals.
Virtual Consultations Eliminate Race and Age Disparities in Transplant Access
To reduce these systemic barriers, researchers partnered with community sites in Appalachian areas to offer virtual consultations with a bone marrow transplant doctor. This model allowed patients to remain in their home environments while clinicians reviewed all medical records remotely. When researchers evaluated this strategy across the patient population, virtual guidance mitigated geographic differences and eliminated age and race disparities in transplant access, effectively equalizing access.
Telehealth Visits Spare Patients Unnecessary Travel and Streamline Care
The virtual care model also spared certain patients unnecessary travel. Out of a cohort of 35 patients evaluated via virtual visits, six were determined not to need a transplant, were ineligible due to various medical factors, or had precursor conditions rather than active myeloma. For those confirmed as transplant-eligible, the initial virtual appointment streamlined the process for subsequent in-person visits.
Implementation Barriers Facing Telehealth Expansion
Despite the clinical benefits, expanding telehealth programs involves distinct logistical hurdles. Insurance restrictions and state-line regulations often prevent physicians from seeing patients across state borders, alongside specific Medicare barriers. Some patients feel hesitant about visiting large cancer centers due to complex logistics like parking and shuttles, preferring local community health facilities.
Future Directions for Cellular Therapy and Clinical Trials
Building on these initial findings, researchers are exploring how to adapt the telehealth model for chimeric antigen receptor T-cell therapy and other cellular therapies. Future initiatives aim to develop collaborative digital interfaces that help patients access clinical trial information remotely, expanding expert consultations for individuals with low-risk monoclonal gammopathy of undetermined significance.
Frequently Asked Questions About Telehealth and Myeloma Care
Which patient groups historically had the lowest rates of receiving a stem cell transplant?
Older patients, Black or African American individuals, and those from rural socioeconomic areas such as Appalachian Ohio were identified as the least likely to receive an autologous stem cell transplant in the study of nearly 2,000 patients.
How many patients were evaluated in the virtual visit cohort subset?
A small cohort of 35 patients underwent virtual evaluations, which resulted in six individuals being informed they either did not require a transplant, had precursor conditions rather than myeloma, or were medically ineligible.
Where was the study on improving stem cell transplant access published?
The research, titled “Moving Mountains: Improving Access to Autologous Stem Cell Transplant for Vulnerable Patient Populations,” was published in the journal Cancers in 2026.
Keep reading